Egg Enclosed In Shell Or A Part Thereof (e.g., Eggshell, Egg Yolk, Etc.) Patents (Class 424/581)
-
Patent number: 7947298Abstract: An animal repellent composition is disclosed that comprises a carrier base and a repellent material. The carrier base and the repellent material are mixed together in a resulting formulation that is used to provide a natural means of deterring unwanted pests and animals from the area in which the composition is used. The composition may also be used as an animal attractant depending on the formulation of the mixed materials. The formulation of the composition can be varied to produce mixtures with different consistencies and properties.Type: GrantFiled: June 11, 2007Date of Patent: May 24, 2011Inventor: Gregory A. La Torre
-
Publication number: 20110117207Abstract: A method to treat and alleviate symptoms of joint pain in an individual is accomplished by administering a therapeutic amount of fowl eggshell membrane or processed eggshell membrane preparations in synergistic combination with other active constituents in an oral dosage form.Type: ApplicationFiled: November 16, 2010Publication date: May 19, 2011Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International State of Incorporation:Inventors: John A. MINATELLI, W. Stephen Hill, Michael Cielensky
-
Patent number: 7906149Abstract: A method for treating oleoresin induced allergic dermatitis by topically contacting an affected area with a therapeutically effective amount of one or more biopolymers for a sufficient amount of time to enable the one or more biopolymers to have an effect and removing the one or more biopolymers from the affected area. The oleoresin can be urushiol, isosolenopsin A, or a combination thereof. The one or more biopolymer can be albumin. The one or more biopolymers can provide a localized anti-inflammatory effect.Type: GrantFiled: May 25, 2007Date of Patent: March 15, 2011Assignee: Boval Company, L.P.Inventor: Cody L. Yarborough
-
Publication number: 20110020316Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.Type: ApplicationFiled: July 21, 2010Publication date: January 27, 2011Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa InternationalInventors: John A. Minatelli, W. Stephen Hill, Swati Sebastian Thomas, Lingan Rajendran, Rudi E. Moerck
-
Publication number: 20110020466Abstract: Fertilized egg isolate, methods for preparing the fertilized egg isolate and uses thereof for treating mental health disorders and disease or conditions mediated by or associated with one or more glutamate receptors or by the neurokinin 2 (NK2) receptor.Type: ApplicationFiled: January 9, 2009Publication date: January 27, 2011Applicant: United Paragon Associates Inc.Inventors: Jerald Bain, Hao Chen, Joel Sadavoy, David Arthur Weissman
-
Publication number: 20110014178Abstract: An antimicrobial composition and a method for administering the antimicrobial composition through the water or feed of livestock, wherein the antimicrobial composition is made up of lysozyme and various other agents that act synergistically with lysozyme, such as, dried egg powder, albumen, a sequestering agent and/or a lantibiotic. The composition is used to inhibit the growth of, and diseases and epidemiological significant effects caused by, Clostridium perfinigens, E, coli and Salmonella, in the gut of livestock. More particularly, the antimicrobial composition and method relate to a feed additive that can be administered to poultry and/or swine through their feed. The use of such a feed additive may also inhibit other enteric pathogens that may be present in the gut of livestock.Type: ApplicationFiled: April 1, 2010Publication date: January 20, 2011Applicant: NEOVA TECHNOLOGIES, INC.Inventors: Stephen R. Smith, Stewart J. Ritchie, Guopeng Zhang
-
Publication number: 20100330192Abstract: The present invention is related to a method for the prevention and possibly the treatment of chronic diseases, preferably inflammatory associated chronic diseases that may affect an animal including a human, by the administration of a sufficient amount of a (functional) food or feed to the diet of this animal.Type: ApplicationFiled: February 25, 2008Publication date: December 30, 2010Inventor: Fabien De Meester
-
Publication number: 20100254961Abstract: A water-soluble electrospun sheet, containing a water-soluble base material made of at least one material selected from a group consisting of: high-molecular proteins and decomposition products thereof; cellulose-based polymers; plant-based polymers and decomposition products thereof; vinyl-based polymers; acrylic-based polymers; and water-soluble polysaccharides; is provided. In addition to the water-soluble base material, the sheet may further contain at least one functional component selected from among: emulsifying components; stabilizing components; antimicrobial components; humectant components; skin-whitening components; anti-ultraviolet components; astringent components; keratin-softening components; anti-inflammatory components; and coloring components.Type: ApplicationFiled: September 4, 2008Publication date: October 7, 2010Applicant: Taiyokagaku Co., Ltd.Inventors: Toshihiko Nishio, Hidetoshi Sugino, Tsutomu Okubo, Shoichi Ishigaki
-
Patent number: 7785569Abstract: A standardized, lyophilized edible food containing a biologically safe stable marker for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient.Type: GrantFiled: May 9, 2003Date of Patent: August 31, 2010Assignee: Advanced Breath Diagnostics, LLCInventors: Keith Darrel Evans, Stanley John Konopka, Kerry Clepper Bush
-
Patent number: 7758893Abstract: The present invention relates to an enteral composition containing phospholipids, triglycerides and cholesterol or precursors thereof, which can be used in the treatment of sepsis. With the composition of the invention the natural level of chylomicrons is maintained, in particular in gut associated lymphoid tissue (GALT), which ensures that most of LPS and/or LTA which are released in the body can be neutralized, substantially decreasing the risk of locally occurring high levels of LPS and/or LTA and thus sepsis.Type: GrantFiled: July 26, 2002Date of Patent: July 20, 2010Assignee: N.V. NutriciaInventors: Robert Johan Joseph Hageman, Gelske Speelmans, Adrianus Johannes Maria Vriesema
-
Patent number: 7744625Abstract: The present invention provides compositions and methods for use in treatment of premature rupture of membrane. The compositions of the invention include a therapeutic amount of an avian thick egg white composition. Preferably, the compositions include the purified thick egg white protein, ovomucin. The methods of the invention involve injecting an effective amount of the compositions into the prematurely ruptured amniotic sac of a patient in order to seal the rupture.Type: GrantFiled: May 13, 2002Date of Patent: June 29, 2010Inventor: David Berry
-
Publication number: 20100151040Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.Type: ApplicationFiled: December 9, 2009Publication date: June 17, 2010Applicant: AAR Pharma Adler ApothekeInventor: Michel O. Ruepp
-
Publication number: 20100003206Abstract: The present invention is a cosmetic composition comprising a water-soluble protein-based film-forming agent, the film-forming agent having a tertiary structure capable of undergoing a helix-coil transformation, a protease inhibitor in an amount sufficient to protect the protein on the stratum corneum and a cosmetically acceptable vehicle so that the protease inhibitor prolongs the pulling effect of the film-forming agent.Type: ApplicationFiled: August 14, 2009Publication date: January 7, 2010Inventors: Paolo Ulderico Giacomoni, Abul M. Manirazman, Peter J. Lentini, Gedeon Harvey
-
Publication number: 20090317484Abstract: A salivary substitute is produced from egg white so as to have chemical, rheological and physiological properties that are analogous to those of natural human saliva. A packaging containing the salivary substitute and uses of the salivary substitute are also disclosed.Type: ApplicationFiled: August 28, 2007Publication date: December 24, 2009Applicant: UNITHER DEVELOPPEMENTInventors: Jean Deymes, Philippe Perovitch
-
Publication number: 20090274770Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.Type: ApplicationFiled: May 7, 2009Publication date: November 5, 2009Applicant: REGENICS ASInventors: Runhild Gammelsaeter, Jan Remmereit
-
Publication number: 20090263494Abstract: Applying the bark of the mariposa Manzanita shrub either mixed into a hot tea or added to mayonnaise and zinc for open sores will cure the herpes virus.Type: ApplicationFiled: April 21, 2008Publication date: October 22, 2009Inventor: Robert David Emerson
-
Publication number: 20090175927Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products. Said components can also be synthesized.Type: ApplicationFiled: May 11, 2007Publication date: July 9, 2009Applicant: Regenics A/SInventors: Runhild Gammelsaeter, Jan Remmereit
-
Publication number: 20090092639Abstract: Methods and compositions for increasing antibody titer in egg yolks and for using the antibodies are disclosed.Type: ApplicationFiled: December 17, 2008Publication date: April 9, 2009Inventors: Mark E. Cook, David L. Trott, Mingder Yang
-
Publication number: 20090074818Abstract: The invention relates to a composition for storage and development of eggs from helminthic parasites, where the composition further comprises a liquid carrier having a pH value of below 7 at a temperature of from 1° C. to ambient temperature. The liquid carrier can be sulphuric acid, H2SO4 with a pH in the range of from O to 2, and antibiotics can be added. The invention further relates to a method for treating, ameliorating, prophylactic or curative, an autoimmune or allergic disease in an individual, animal or man, using eggs being separated from the composition. The present invention also relates to methods for isolation, embryonation and preservation of eggs of helminthic parasite, and to a method for producing a pharmaceutical composition comprising a helminthic parasite preparation. The helminthic parasite eggs may be from the pig whipworm; Trichuris suis ova (TSO).Type: ApplicationFiled: December 29, 2006Publication date: March 19, 2009Inventors: Christian Mollin Outzen Kapel, Allan Roepstorff, Stig Milan Thamsborg
-
Patent number: 7479287Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.Type: GrantFiled: July 31, 2006Date of Patent: January 20, 2009Assignee: I.B.R., Israeli Biotechnology Research, Ltd.Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
-
Publication number: 20080286200Abstract: A standardized, lyophilized edible food containing a biologically safe stable marker for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient.Type: ApplicationFiled: May 15, 2008Publication date: November 20, 2008Applicant: Advanced Breath Diagnostics, LLCInventors: Kerry C. Bush, Keith D. Evans, Stanley J. Konopka
-
Patent number: 7186424Abstract: The present invention is a multifunctional nutrient supplement and a process for creating the supplement. The supplement comprises a mixture of lecithin, ginkgo biloba and wheat germ oil. The supplement is made with a five step formation process. The first step of the process uses CO2 supercritical extraction to remove cholesterol, glyceride and fatty acids from an egg yolk. Wheat germ oil is then obtained from dried wheat germ using CO2 supercritical extraction. Gingko biloba is then removed from ginkgo leaves using CO2 supercritical extraction. The egg yolk/lecithin from the first extraction is then combined with the wheat germ oil from the second extraction. Ethanol is then added to the mixture of lecithin and wheat germ oil and low temperature vacuum distilled to create a lecithin and wheat germ oil mixture. The ginkgo biloba extract is then added to the lecithin/wheat germ oil mixture to create the nutrient supplement.Type: GrantFiled: September 23, 2004Date of Patent: March 6, 2007Inventors: Ming Xie, Dingzhong Xie, Yong Feng, Hui Zeng
-
Patent number: 7087429Abstract: A process for obtaining a substance with growth promoting activity that includes the step of isolating perivitelline fluid from a fertilized egg of a horseshoe crab. Also, a process for proliferating cells including the steps of isolating perivitelline fluid from a fertilized egg of a horseshoe crab and growing the cells in the presence of the isolated perivitelline fluid.Type: GrantFiled: March 24, 2004Date of Patent: August 8, 2006Assignee: Department of Biotechnology and Council of Scientific and Industrial ResearchInventors: Pradeep Bhaskar Parab, Anil Chatterji
-
Patent number: 7083809Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-?), interleukin-1-beta (IL-1?), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.Type: GrantFiled: February 11, 2003Date of Patent: August 1, 2006Assignee: Arkion Life Sciences, LLCInventors: Subramanian Iyer, William L. Johnson, Lance Nguyen, Steven C. Ross, Ruye Xing
-
Patent number: 7033601Abstract: The present invention is a composition and method for repelling squamate reptiles, such as without limitation snakes. The composition comprises mint oil, garlic oil, putrescent egg solids, thyme oil white, sodium lauryl sulfate and water. This composition is applied to snakes' habitats or perimeters around homes, buildings, patios, decks and the like to repel squamate reptiles, such as without limitation snakes.Type: GrantFiled: May 10, 2005Date of Patent: April 25, 2006Assignee: Liquid Holding Company, Inc.Inventor: George Ferko, IV
-
Patent number: 7011853Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.Type: GrantFiled: December 21, 2001Date of Patent: March 14, 2006Assignee: AAR Pharma Adler ApothekeInventor: Michel O. Ruepp
-
Patent number: 6936284Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an anticancer activity and is selectively cytotoxic to cancer cells. A composition having an anticancer effect is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and a dry product of Theaceae Camellia. Also, a composition having an anticancer activity is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and/or a dry product of Theaceae Camellia together with a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.Type: GrantFiled: October 9, 2002Date of Patent: August 30, 2005Assignee: Iijima CorporationInventors: Hideshi Iijima, Aizo Iijima
-
Patent number: 6866868Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.Type: GrantFiled: September 15, 2003Date of Patent: March 15, 2005Assignee: 4Life Research, LCInventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
-
Patent number: 6863903Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.Type: GrantFiled: February 7, 2003Date of Patent: March 8, 2005Assignee: Rural Patent Svenska ABInventors: Stefan Lange, Leif Göransson, Ivar Lönnroth
-
Publication number: 20040219171Abstract: The present invention is directed to processes and compositions for protecting host animals (e.g., chickens) from exposure to virulent infectious bronchitis virus. In ovo administration of live, avirulent strains of IB at appropriate dosage levels on a per egg basis provides an effective and efficient vaccination having acceptable safety and efficacy features.Type: ApplicationFiled: June 1, 2004Publication date: November 4, 2004Applicant: WyethInventors: Berend Jongsma, Frans Gerrit Davelaar, Marinus Wynand Weststrate
-
Patent number: 6803035Abstract: A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.Type: GrantFiled: January 22, 2002Date of Patent: October 12, 2004Assignee: Arkion Life SciencesInventors: Hellen Chaya Greenblatt, Orn Adalsteinsson, David A. Brodie, Henry Jacoby
-
Patent number: 6790457Abstract: Disclosed is an immunocontraceptive vaccine composition comprising a teleost homolog of zona pellucida (TH-ZP), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a fish, and a method for its use. Also disclosed is immunocontraceptive vaccine composition comprising an antigen from an inner perivitelline layer (IPVL), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a bird, and a method for its use.Type: GrantFiled: November 27, 2001Date of Patent: September 14, 2004Assignee: Dalhousie UniversityInventors: Robert Brown, Bill Pohajdak, Janet Horrocks, Leslie McLaren
-
Patent number: 6776991Abstract: A method for treating priapism in a mammal by administration of a botulinum toxin.Type: GrantFiled: June 26, 2002Date of Patent: August 17, 2004Assignee: Allergan, Inc.Inventor: Markus K. Naumann
-
Patent number: 6720010Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an antihepatitic activity. A composition having an antihepatitic activity is provided, which comprises a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia. The composition may contain a dry product of Angelica keiskei and optionally a dry product of Theaceae Camellia. The compositions have antihepatitic activity and are derived from natural substances.Type: GrantFiled: October 7, 2002Date of Patent: April 13, 2004Assignee: Iijima CorporationInventors: Hideshi Iijima, Aizo Iijima
-
Publication number: 20030219492Abstract: The present invention provides compositions and methods for use in treatment of premature rupture of membranes. The compositions of the invention include a therapeutic amount of an avian thick egg white composition. Preferably, the compositions include the purified thick egg white protein, ovomucin. The methods of the invention involve injecting an effective amount of the compositions into the prematurely ruptured amniotic sac of a patient in order to seal the rupture.Type: ApplicationFiled: October 23, 2002Publication date: November 27, 2003Inventor: David Berry
-
Patent number: 6652846Abstract: The invention relates to attractants for use in yellow jacket traps. The attractants have improved overall effectiveness in attracting yellow jackets, in attracting a broader spectrum of yellow jacket species and in attracting yellow jackets in the several phases of their life cycles when their food requirements vary. The attractants are distinguished by the inclusion of a weak acid in the attractant formulation. The preferred weak acid is acetic acid and its preferred form is a vinegar.Type: GrantFiled: December 7, 2000Date of Patent: November 25, 2003Inventor: Roger H. Long
-
Publication number: 20030211226Abstract: A method of detoxifying the egg of puffer fish for creating healthy foodstuffs which includes the steps of heating the eggs of puffer fish and ginger root at a temperature of 100-200° C. for 30-40 minutes and drying the heated egg composition, and repeating the heating and drying steps a multiplicity of times to produce a detoxified product.Type: ApplicationFiled: August 6, 2002Publication date: November 13, 2003Inventors: Sang Kuen Kim, Byoug Ki Kim, Jung Sik Shin, Jin San Shin
-
Patent number: 6642202Abstract: The object of the present invention is to allow an egg originally having almost no active oxygen eliminating ability, to strongly possess an active oxygen eliminating ability. It was found that an egg containing a high level of iodine (4.2 ppm or more) has an ability to eliminate active oxygen, which acts harmfully on the human body.Type: GrantFiled: March 12, 2002Date of Patent: November 4, 2003Assignee: Nosan CorporationInventors: Kunitoshi Sekimoto, Akiko Matsuki, Ayuko Kashimori
-
Patent number: 6627229Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.Type: GrantFiled: June 23, 2001Date of Patent: September 30, 2003Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
-
Publication number: 20030180318Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an anticancer activity and is selectively cytotoxic to cancer cells. A composition having an anticancer effect is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and a dry product of Theaceae Camellia. Also, a composition having an anticancer activity is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and/or a dry product of Theaceae Camellia together with a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.Type: ApplicationFiled: October 9, 2002Publication date: September 25, 2003Applicant: Iijima CorporationInventors: Hideshi Iijima, Aizo Iijima
-
Publication number: 20030175359Abstract: The object of the present invention is to allow an egg originally having almost no active oxygen eliminating ability, to strongly possess an active oxygen eliminating ability. It was found that an egg containing a high level of iodine (4.2 ppm or more) has an ability to eliminate active oxygen, which acts harmfully on the human body.Type: ApplicationFiled: March 12, 2002Publication date: September 18, 2003Inventors: Kunitoshi Sekimoto, Akiko Matsuki, Ayuko Kashimori
-
Publication number: 20030152641Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-&agr;), interleukin-1-beta (IL-1&bgr;), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.Type: ApplicationFiled: February 11, 2003Publication date: August 14, 2003Inventors: Subramanian Iyer, William L. Johnson, Lance Nguyen, Steven C. Ross, Ruye Xing
-
Publication number: 20030143285Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.Type: ApplicationFiled: February 7, 2003Publication date: July 31, 2003Inventors: Stefan Lange, Leif Goransson, Ivar Lonnroth
-
Publication number: 20030143284Abstract: The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.Type: ApplicationFiled: February 7, 2003Publication date: July 31, 2003Inventors: Stefan Lange, Leif Goransson, Ivar Lonnroth
-
Publication number: 20030133989Abstract: The present invention provides a skin care product comprising whole egg, an emollient substance and a humectant substance, colostrum, lactoferrin and/or methyl sulfonyl methane (MSM).Type: ApplicationFiled: October 1, 2002Publication date: July 17, 2003Inventor: Michael Marenick
-
Publication number: 20030068314Abstract: A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.Type: ApplicationFiled: January 22, 2002Publication date: April 10, 2003Inventors: Hellen Chaya Greenblatt, Orn Adalsteinsson, David A. Brodie, Henry Jacoby
-
Patent number: 6541447Abstract: A composition for wound healing and hair growth is disclosed. The composition comprises at least 5.0% by weight of ovalbumin, about 1.0% phenoxyethanol, about 0.5% carbomer, and about 0.3% triethanolamine. The composition may be in the form of a cream, powder, lotion, gel, emulsion, or ointment. Its method for use in wound healing and for hair growth is also disclosed.Type: GrantFiled: September 1, 1999Date of Patent: April 1, 2003Assignee: B & M Healthcare Technologies, Inc.Inventor: Monica E. Dawson
-
Publication number: 20030059480Abstract: Although compositions from seaweed have long been sought after for beneficial properties for the skin, the ability to produce efficacious compositions has been elusive. An intra-lamellar gel, produced from marine algae, has been found to enhance the condition of skin and hair. Milt, optionally in combination with intra-lamellar gel, also provides a composition useful for application to the skin or hair.Type: ApplicationFiled: March 29, 2002Publication date: March 27, 2003Inventor: Diane C. Boratyn
-
Patent number: 6537588Abstract: The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.Type: GrantFiled: July 6, 2001Date of Patent: March 25, 2003Assignee: Rural Patent Svenska ABInventors: Stefan Lange, Leif Göransson, Ivar Lönnroth
-
Patent number: 6534097Abstract: A pest deterrent compound includes water, calcium carbonate and hydrogen sulfide. The compound is successful in deterring white flies and other destructive insects from attacking plants. The plant is protected by pouring a liquid solution onto the plant and the ground underneath and around the plant. The compound is absorbed into the plant's leaves and roots and acts as a deterrent against destructive insects. The pest deterrent compound is given in the following formula.Type: GrantFiled: July 11, 2002Date of Patent: March 18, 2003Inventor: Betty Baggott